Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Marex Group Limited Ordinary Shares (MRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Marex Group Limited Ordinary Shares — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Marex Group Limited Ordinary Shares trades at $71.17 (market cap $5.18B). The key difference: Definium Therapeutics Inc. Common Shares and Marex Group Limited Ordinary Shares are close in size by market cap, and Marex Group Limited Ordinary Shares pays a 0.89% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Marex Group Limited Ordinary Shares for 0 Days on average.
| DFTX | MRX | |
|---|---|---|
Market Cap | $4.71B | $5.18B |
Volume | 1,966,636 | 665,047 |
Sector | Health | Financials |
52-Week High | $48.45 | $78.27 |
52-Week Low | $10.68 | $29.92 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.67B | $8.26B |
Dividend Yield | — | 0.89% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Marex Group Limited Ordinary Shares
Marex Group provides financial services across commodities, financial markets, and corporate clients. Its services include clearing, agency and execution, market making, hedging, and securities services.
Read more on MRX →
